 SAN DIEGO--BUSINESS WIRE--Ligand Pharmaceuticals Incorporated NASDAQ: LGND today reported financial results for the three and 12 months ended December 31, 2020 and provided an operating forecast and program updates. Ligand management will host a conference call today beginning at 8:30 a.m. Eastern time to discuss this announcement and answer questions. 2020 was a stellar year for Ligand, and we are well positioned for an even better 2021. I am extremely proud of how well the team has met b 